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A mammalian histidine decarboxylase was first de¬ 
scribed in 1936 by Werle (64). Since then, enzymes that 
catalyze the decarboxylation of histidine have been demon¬ 
strated in many mammalian species and tissues. It has 
become clear that all of these enzymes are not identical, 
that they have different properties in different tissues, 
and that species differences do exist. A broad classifi¬ 
cation can be made, however, on the basis of substrate 
specificity, the pH at which the enzyme exhibits maximal 
activity, and the effects of various enzyme inhibitors and 
activators. Two main types emerges (i) an aromatic 
L-amino acid decarboxylase (29) which decarboxylates a 
wide variety of natural and synthetic aromatic amino acids 
including histidine (29, 62); this enzyme exhibits maximum 
activity in an alkaline medium (pH >8), is strongly in¬ 
hibited by alpha-methyl DOPA (a strong inhibitor of 
3,4-dihydroxyphenylalanlne (DOPA) decarboxylase), and is 
activated in vitro by the addition of a small amount of 
benzene (6l). It is probably identical to the DOPA 
decarboxylase and 5-hydroxytryptophan (5-HTP) decarboxyl¬ 
ase of rabbit and guinea pig kidney (29, 45, 62). (li) a 
specific L-histidine decarboxylase which seems to decar- 
boxylate only histidine, is most active at slightly acid 

2- 
or neutral pH, is inhibited only slightly or not at all 
by alpha-methyl DOPA, and is either unaffected or 
inhibited in vitro by the addition of a small amount of 
benzene. These properties of histidine decarboxylase from 
many mammalian sources are summarized in Table 1. In 
addition, the affinity for the substrate, L-histidine, 
differs greatly between these two types, specific histidine 
decarboxylase having a much lower Michaelis-Menten constant 
(Km) than aromatic L-amino acid decarboxylase (33, 63). 
Both types of enzymes share a requirement for the 
coenzyme pyridoxal-5-phosphate, and consequently both are 
Inhibited by compounds such as hydroxylamine and semi- 
carbazlde which react with pyridoxal phosphate (3, 8, 9, 
10, 31, 38, 41, 46, 48, 54). The specific enzyme appears 
to bind this cofactor more loosely than aromatic amino 
acid decarboxylase, the former enzyme losing activity much 
more rapidly with dialysis (46, 48). Although a metal ion 
requirement has been demonstrated for bacterial histidine 
decarboxylase (6), this has not been shown for the mam¬ 
malian enzyme. The addition of EDTA (lO-^ M) has no 
effect on the mammalian enzyme activity (63). 
In addition to the classification discussed above, 
which considers only the jUn vitro biochemical behavior of 
the enzymes, groupings have been made which include 
functional considerations as well. In all the tissues of 
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the mouse and rat except blood, Schayer has found histidine 
decarboxylase activity which has been "induced" in the 
animals by exposure to stress, such as cold, bacterial 
endotoxin, catechol amines, trauma and delayed hyper¬ 
sensitivity reactions (49, 50, 51, 52, 55, 59). This 
"induced" enzyme, according to Schayer, is Intimately 
involved in the local production of unbound histamine 
which, acting as an antagonist of epinephrine, helps 
maintain homeostasis of the microcirculation (50). Schayer 
(49, 51, 52) and others (59) have made extensive inves¬ 
tigations concerning the effects of glucocorticoids on the 
inducible enzyme. The in vitro properties of this enzyme 
have not been well characterized however. It has a pH 
optimum ranging from pH 7.4 to 8 (52) but the effects of 
inhibitors and benzene have not been carefully investigated. 
Schayer suggests that the Inducible enzyme is located in 
the capillary endothelial cells (51). 
Another point of view has been championed by Kahlson, 
who has found histidine decarboxylase activity with the 
characteristics of the specific enzyme in tissues 
characterized by rapid growth, such as fetal rat liver 
(14, 18, 19, 20, 21), regenerating rat liver (14), rat 
hepatoma (25), rat bone marrow (15), ascites tumor (16), 
and healing wounds (13). He suggests that this enzyme 
activity is related to the general process of growth (12). 
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However, this view has been challenged by many inves¬ 
tigators who have failed to find high enzyme levels in the 
tissues of other mammalian fetuses (22, 24, 58) and in 
other rapidly growing tissues (32, 41, 56). 
A strong stimulus for the continued Investigation of 
histidine decarboxylase has been the search for a specific 
inhibitor of the enzyme. The availability of a "histamine- 
free" animal to investigations of the physiological role(s) 
of histamine, and the possible therapeutic uses of such an 
inhibitor are of obvious interest. 
That the specific enzyme is the primary mediator of 
endogenously produced histamine is suggested by its greater 
affinity for histidine and by the observation that alpha- 
methyl DOPA, a strong inhibitor of the aromatic amino acid 
decarboxylase, does not significantly alter urinary histamine 
excretion or whole mouse histamine levels (63). Studies In 
the rat also suggest that the specific enzyme is responsible 
for histamine synthesis in vivo (17, 25). Thus, if 
inhibition of histamine production is of interest, it is 
reasonable to consider first the properties of the specific 
histidine decarboxylase. 
An active source of this enzyme is the transplantable 
mouse mastocytoma (8, 39, 40, 63). Some of the character¬ 
istics of this enzyme are included in Table 1. DOPA de¬ 
carboxylase and 5-HTP decarboxylase activities have also 
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been described in this tissue (7, 8, 39, 40), but It has 
not been determined If these activities are the property 
of one or of several enzymes. Although mastocytoma 
histidine decarboxylase has been partially purified (2) 
it's substrate specificity has not been definitely estab¬ 
lished. The enzyme has been tested with a number of 
inhibitors (1, 63). 
Experiments will be discussed in this paper which 
suggest that mouse mastocytoma histidine decarboxylase is 
specific for histidine and that the observed DOPA and 
5-HTP decarboxylase activities are the property of another 
enzyme present in the tissue. In addition, the observed 
change in pH optimum of the mastocytoma enzyme at different 
substrate concentrations will be discussed with reference 
to similar finding previously reported by Hakanson for 





Radioactive chemicals: DL-hlstidine-l-C •2HC1 was 
obtained from Merck, Sharp and Dohme of Canada, Ltd.; 
DL-3,4-dlhydroxyphenylalanine-l-C1^ was purchased from 
the New England Nuclear Corp., Boston; DL-5-hydroxy- 
tryptophan-l-C^ was supplied by the ChemTrac Corp., 
Cambridge. 
DL-histidine*HC1.1^0, DL*-3»4~dihydroxyphenylalanine, 
DL-5-hydroxytryptophan*H20 and pyridoxal-5-phosphate were 




Preparation of Enzymes 
Mastocytoma,, All procedures Involving enzymes were 
carried out at 0 to 3°C. A water extract of the trans¬ 
plantable mouse mastocytoma of Furth, et al. (4) was used 
as the starting material. It was lyophlllzed, powdered 
and stored at ~70°C. This powder was suspended in 40 
volumes of water, stirred for three hours to redissolve 
most of it, and then centrifuged at 35,000 x g for 30 
minutes. To the supernatant solution 0.05 N HC1 was added 
slowly (>1 hour) to bring the pH to 4.7 and precipitate 
the bulk of the proteins. The solution was stirred an 
additional one hour and then centrifuged. The supernatant 
fluid was discarded and the precipitate was homogenized 
with sufficient Teorell-Stenhagen universal buffer^ 
(diluted 1:1 with water), pH 7, to regain the original 
volume. The pH pf the resulting solution-suspension was 
6.2, so a small amount of 0.05 N NaOH was added slowly to 
bring the pH to 6.8 and allow the precipitate to completely 
redissolve. To this solution 0.05 N HC1 was again added 
slowly to bring the pH to 5.3. The precipitate which 
formed was removed by centrifugation and discarded, and the 
1. Teorell-Stenhagen universal buffer (60) contains 
0.0100 M phosphate, 0.0114 M borate and 0.0067 M citrate. 
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pH of the supernatant solution was lowered further to 
pH 4.8. The precipitate which formed was recovered by 
centrifugation, dissolved in Teorell-Stenhagen buffer 
(diluted 1:1 with water) and the solution was adjusted 
to pH 6.8 with 0.05 N NaOH. This solution, which con¬ 
tained the protein fraction which precipitated between 
pH 5.3 and 4.8, constituted the semipurifled histidine 
decarboxylase used In further studies. It represented a 
3 to 4 fold purification of histidine decarboxylase and 
contained 21$ of the initial enzyme activity. The activity 
of this preparation was stable for several weeks when 
frozen. 
Rat Fetus. Histidine decarboxylase from fetal rats 
was purified by selective heat denaturation and ammonium 
sulfate fractionation according to Hakanson (10). However, 
the protein fraction which precipitated between 25-40$ 
saturation was used as the final preparation and was not 
fractionated further. It is referred to as purified fetal 
histidine decarboxylase in this paper. 
Assay of Enzyme Activity 
Histidine decarboxylase. The enzyme preparation, 
pyrldoxal phosphate and Teorell-Stenhagen buffer, pH 6.8, 
were mixed together, Incubated at 37° for 20 minutes to 
allow interaction between apo- and coenzyme, and cooled 
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again to 0°. Substrate was then added and the pH care¬ 
fully adjusted to 6.8 with a small amount of 0.05 N HC1 or 
NaOH. Three 0.5 ml aliquots of this mixture were then 
taken and incubated in rubber-stoppered 5-ml Erlenmeyer 
flasks for 30 minutes at 37° in a shaking incubator. Unless 
otherwise stated, each aliquot contained 0.1 ml of the 
enzyme preparation, 2.0 x 10”3 m pyrldoxal phosphate, 
1.0 x KT3 M DL-histldine-l-Cl2f (100,000 count s/minute), 
and enough buffer to bring the volume to 0.5 ml. When 
incubations were carried out at other than pH 6.8, Teorell- 
Stenhagen buffer was used at a pH which required as little 
final adjustment as possible after addition of the substrate. 
Following incubation the samples were cooled to 0° and made 
alkaline by the injection of 0.1 ml of 0.1 N NaOH through 
14 
the rubber stopper. This prevented loss of C 02 when the 
stoppers were removed. Ampoules containing 2.0 ml of 
phenylethylamlne-POPOP-PPO solution were attached as 
described by Aures and Clark (l). The subsequent absorption 
14 
and liquid scintillation counting of C 02 was performed 
as described by these authors. Blanks were identical except 
that enzyme was either omitted or denatured by boiling for 
ten minutes. 
DOPA decarboxylase. An attempt was made to measure 
DOPA decarboxylase activity in an Identical manner to that 
used for histidine decarboxylase, using DL-DOPA-1-C1^ as 
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substrate. However, It was found that under these con- 
14 
dltions a non-enzymatic breakdown of the C -labeled 
substrate occurred, often yielding very high and un- 
reproduclble blank values. This non-enzymatic breakdown 
was accelerated in an oxygen atmosphere, depressed slightly 
by incubation in a nitrogen atmosphere, and unaffected by 
the addition of EDTA (10~^ M) or serum protein (2 mg/ml). 
The addition, however, of certain fetal rat tissue extracts, 
glutathione (10"^ M) or ascorbic acid (10”^ M) completely 
suppressed the non-enzymatic breakdown. To show that the 
blank was due to the decomposition of DOPA-l-C1^ and not 
of a radioactive contaminant, the radiopurity of the com¬ 
pound was confirmed by paper chromatography. DOPA was 
eluted from the paper and shown to undergo the same non- 
enzymatic decomposition as the unchromatographed compound. 
Because of these findings the DOPA decarboxylase assays 
were performed with the addition of glutathione to the 
incubation mixture. Unless otherwise stated,,each incubate 
contained 0.1 ml of the enzyme preparation, 2.0 x 10 ^ M 
pyrldoxal phosphate, 4.4 x 10 M DL-D0PA-1-Clif (40,000 
counts/mlnute), 1 x lO-^ m glutathione and enough Toorell- 
Stenhagen buffer to bring the volume to 0.5 ml. The pH 
was adjusted to 6.8 following addition of the substrate and 
Incubation time was 10 minutes at 37° • A 20 minute 
incubation before the addition of substrate and all other 

-13- 
aspects of the assay were identical with the histidine 
decarboxylase assay. Figure 1 illustrates that the addition 
of 10-3 ^ glutathione did not significantly affect the DOPA 
decarboxylase activity of mastocytoma extract, Indicating 
that this inhibitor of the non-enzymatic decomposition of 
DOPA had no effect on the enzymatic decarboxylation of the 
compound. 
5-HTP decarboxylase. This assay was identical to the 
histidine decarboxylase assay except that Incubations were 
done at pH 8.0 with a substrate concentration of 4.4 x 10"^ M 
DL-5-HTP-l-C1^ (110,000 counts/minute). 
Protein 
Protein concentration was determined by the method of 

















Figure 1. Lack of effect of Glutathione 
on the DOPA decarboxylase activity of Mastocytoma extract 
O-O Glutathione, 10~^ M 




Table 2 shows the activity of mastocytoma extract and 
of the semipurified enzyme preparation with different 
substrates. While purification Increased the specific 
activity of histidine decarboxylase 3.5 fold, the DOPA 
decarboxylase and 5-HTP decarboxylase activities decreased 
markedly. This suggests that (l) the histidine decarboxylase 
is a different enzyme from DOPA and 5-HTP decarboxylase, 
(ii) a single enzyme responsible for decarboxylation of all 
three amino acids had undergone alteration, or (lii) the 
fractionation procedure had removed or altered some other 
substance(s) present in the original tissue extract that 
variously affected the three decarboxylase activities of 
a single enzyme. That the first possibility is probably 
correct is supported by the findings demonstrated in 
Figure 2. This shows that when carboxyl-labeled histidine 
and carboxyl-labeled DOPA were incubated together with 
crude mastocytoma extract, the amount of 0*^02 formed was 
far greater than when either substrate was present alone and 
approached the sum of the amounts of 0^^02 formed when each 
substrate was present alone. This finding is characteristic 
of two independent sites of decarboxylation rather than of a 
single site where competition of the two substrates would 
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Table 2. Changes In absolute and relative decarboxylase 
activities of Mastocytoma extract after purification 
Substrate - ny<Moles OO2/3O min./mg protein - 
Crude extract - Semipurlfied 
Purification 
factor 
Histidine 9.6 34 3.5 
DOPA 23.71 4,21 0.18 
5-HTP 5.82 0.22 0.04 
1. Extrapolated from values obtained at 10 min. incubation. 
2. Data obtained from another enzyme preparation in which 
the histidine decarboxylase purification factor was 2.3. 
Table 3. Lack of Inhibition 
of Mastocytoma Histidine decarboxylase by DOPA 
Molar cone. Per cent Activity 
DL-DOPA Crude extract Semipurlfied 
None 100 100 
1 x 10"5 
-4 
96 98 
1 x 10 103 100 
1 x 10-3 98 96 
1 x 10~2 89 85 

















Figure 2. Histidine decarboxylase and DOPA 
decarboxylase activities of mastocytoma extract 
Molar cone. DL-Histidine 
Incubation time was 30 minutes. No glutathione was added. 
o- —o Curve 1. DOPA alone. 
0- ' 0 Curve 2. Histidine alone. 
0- —0 Curve 3. DOPA plus Histidine. 
— — Curve 4. Sum of Curves 1 and 2. 
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Figure 3. Change in pH optimum 
with different substrate concentrations 
O-G 1.0 x 10“2 M DL-Histidine 
0-0 1.0 x 10"3 M 
O--€) 1.0 x 10"4 M 
Q-W 1.0 x 10“5 M 
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take place. Additional evidence is provided in Table 3 
which shows that the histidine decarboxylase activity of 
both the mastocytoma extract and semipurified preparation 
was not inhibited to a significant degree by the addition 
of unlabeled DOPA. 
With the semipurified preparation, the pH at which the 
histidine decarboxylase exhibited maximal activity was found 
to vary with substrate concentration (Figure 3). This is 
in agreement with Hakanson’s findings with the fetal rat (10) 
and rat bone marrow (11) enzymes. 
Fetal rat 
The purified enzyme preparation had a histidine decar¬ 
boxylase activity of 11 m^Moles C02/mg proteln/30 min. This 
compares with an activity of 22 nvqMoles C02/mg protein/30 min. 
reported by Hakanson (calculated from figures in his text) 
with a more purified preparation. 
No DOPA decarboxylase activity could be demonstrated in the 
purified preparation. There was abundant DOPA decarboxylase 
activity in the tissue homogenate, but this was totally lost 
during the heat denaturation step of the purification procedure. 
Comparison of histidine decarboxylase activities of 
homogenates of fetal liver and the remaining fetal carcass 
showed the liver to have 20 times the activity of the remaining 




The semipurlfied mastocytoma histidine decarboxylase 
preparation investigated in this paper was not specific 
for histidine as it still contained some DOPA decarboxylase 
and 5-HTP decarboxylase activity. The evidence presented 
suggests strongly that this was due to contamination of a 
specific histidine decarboxylase by small amounts of another 
enzyme, possibly aromatic L-amino acid decarboxylase, rather 
than a property of the histidine decarboxylase itself. The 
report by Aures and Clark (l) that histidine decarboxylase 
prepared from this same tissue was inhibited 50^ by 
4.0 x 10“3 m l-DOPA and by 1,0 x 10“^ m D-DOPA is not con¬ 
firmed by the data presented here. It is well known that 
DOPA and pyridoxal-5-phosphate react rapidly to form a 
cyclic compound (35, 55). Furthermore, it has been shown 
that high concentrations of DOPA will inhibit DOPA decar¬ 
boxylase and that the Inhibition can be reversed by the 
addition of more pyrldoxal phosphate (55). It is highly 
likely, therefore, that the Inhibition observed by these 
authors was due to sequestration of the coenzyme away from 
the apoenzyme by the added DOPA. In the studies reported 
here the apo- and coenzyme were allowed to react together 
for 20 minutes before substrate or Inhibitor was added, 
thereby minimizing the possibility of coenzyme deficiency 
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due to Interaction with the inhibitor. The otherwise 
curious result of these authors that D-DOPA should be as 
good an inhibitor as L-DOPA is explained if the inhibition 
is considered as due to interaction with the coenzyme, since 
both isomers react equally well with pyridoxal phosphate. 
Unfortunately it was not possible to separate the 
histidine decarboxylase and DOPA decarboxylase activities 
by the simple fractionation procedures employed. All 
fractions were tested for both enzyme activities and none 
convincingly showed an increase of DOPA decarboxylase activity 
relative to the histidine decarboxylase present. It is 
possible that all the fractionation served to do was to 
progressively denature the aromatic L-amlno acid decar¬ 
boxylase present in the initial extract. 
The pH optimum of the mastocytoma histidine decar¬ 
boxylase varied with the substrate concentration (Figure 3). 
Hakanson has reported similar results with purified 
histidine decarboxylase from rat fetus (10) and rat bone 
marrow (ll). He has also shown that the K of fetal rat m 
histidine - decarboxylase decreases as the pH increases. He 
analyzed this phenomenon by considering which ionic species 
of histidine is the actual substrate of the enzyme. Thus, 
when the Km values were recalculated using the concentration 
of the anionic form of histidine (see Table 4 for further 
explanation) as the substrate concentration, the values 
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were almost the same at all hydrogen Ion concentrations, 
~7 -7 
averaging 6 x 10 M (range 4.3-6.9 x 10" M). When the 
other ionic forms of histidine were considered as the 
substrate, the values at different hydrogen ion concen¬ 
trations did not agree nearly so well. He concluded that 
the anionic form of histidine was the actual substrate of 
the enzyme. When this analysis is applied to the findings 
reported in this paper for mastocytoma histidine decarboxyl¬ 
ase, the result is as shown in Table 4. It can be seen that 
whereas the Km values calculated to total histidine con¬ 
centration vary by a factor of 37, those obtained by 
considering the anionic form of histidine as the substrate 
vary only by a factor of 2. Mackay, Riley and Shepherd (33), 
working with the specific histidine decarboxylase of the 
transplantable rat hepatoma have also reported a wide range 
in the Km at different pH values (1.4 x 10“^ M at pH 7.8; 
6.8 x 10"5 ^ pH 5.8), suggesting that this may be a 
general property of the specific histidine decarboxylase of 
many tissues and that the anionic form of histidine Is the 
true substrate of these enzymes. This would be an Important 





Table 4. The Influence of pH on Kffi 
pH Km(total Hd)1 Per cent of K_(anlonlc form)^ 
Histidine in2 
anionic fornr 
6.0 7.1 X 10~4 0.035 2.5 X O
 1 —
J 
6.4 2.7 X 10~4 0.13 3.5 X 10”7 




1 0.37 4.4 X 10"7 











1. K^(total Hd) was estimated from the data presented in 
Figure 3 by use of Llneweaver-Burk plots (27) and was 
calculated using total L-Hi3tldine concentration. 
2. Per cent of Histidine in anionic form represents that 
fraction of L-Histldine present in the following form: 
This fraction was calculated using published (26) 
dissociation constants of histidine. 
3. Km(anionic Hd) is obtained when K is calculated 




Mouse mastocytoma histidine decarboxylase was 
partially purified by fractional precipitation of protein 
with increasing hydrogen ion concentration. Studies 
suggested that the semlpurified preparation contained a 
specific histidine decarboxylase; the small amount of 
DOPA and 5-HTP decarboxylase activity which remained was 
probably due to another enzyme(s). The pH optimum of the 
mastocytoma histidine decarboxylase was found to vary 
inversely with the substrate concentration. The possible 
significance of this observation is discussed with 
reference to the nature of the ionic species of histidine 
utilized as substrate by the enzyme. 
In addition, it was confirmed that fetal rat histidine 
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